Global Disparities in HTLV-1 Research and Response: A Unique Focus on U.S. Afro-Caribbean and Polynesian/Japanese Populations
Year: 2026
Type: article
Abstract: Human T-cell leukemia virus type 1 (HTLV-1) is a neglected retrovirus that causes adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Despite an estimated 5–10 million worldwide infections, surveillance remains limited, particularly among underserved United States (U.S.) populations. This report examines disparities in HTLV-1 research, diagnosis, and care across populations from endemic regions and their U.S. diasporas. Jamaica, Haiti, and Trinidad & Tobago report seroprevalence rates of 1–6%, yet surveillance has declined since the early 2000s. Elevated ATLL incidence among Caribbean-born U.S. residents indicates substantial disease burden despite the absence of population-based HTLV-1 surveillance. Japan’s national antenatal screening programs have reduced transmission, while the United States lacks comparable frameworks. HTLV-1 prevalence among U.S. Pacific Islander populations remains insufficiently characterized, and demographic aggregation limits population assessment. Limited surveillance and barriers to diagnosis leave important uncertainties about the distribution of HTLV-1 infection and associated disease in the United States; ancestry and demographic concentration alone cannot resolve these uncertainties. Drawing on international experience, this report proposes integrating low-cost diagnostics, community-led outreach, and equitable clinical trial participation to improve detection and outcomes. HTLV-1 thus represents not only an infectious disease gap but a marker of enduring global and domestic health inequities.
Source: Pathogens
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7162607663
